During the past decade, BC Diabetes conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BC Diabetes" #1 sponsor was "Acasti Pharma Inc." with 1 trials, followed by "Alessandro Doria" with 1 trials sponsored, "Anji Pharma" with 1 trials sponsored, "Applied Therapeutics, Inc." with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BC Diabetes" #1 collaborator was "Albert Einstein College of Medicine" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Northwestern University Feinberg School of Medicine" with 2 trials as a collaborator, "University of Colorado, Denver" with 2 trials as a collaborator and "University of Michigan" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "BC Diabetes" are "Diabetic Nephropathies" (2 trials), "Corona Virus Infection" (1 trials), "Coronary Artery Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Diabetic Cardiomyopathies" (1 trials). Many other conditions were trialed in "BC Diabetes" in a lesser frequency.

Most popular intervention types in "BC Diabetes" are "Drug" (8 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Allopurinol" (2 trials), "% time 70-180 mg/dL" (1 trials), "% time above 180 mg/dL" (1 trials) and "% time above 250 mg/dL" (1 trials). Other intervention names were less common.

The vast majority of trials in "BC Diabetes" are 8 trials for "All" genders.

Currently, there are NaN active trials in "BC Diabetes". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in BC Diabetes, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in BC Diabetes, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".